FNP-223, previously known as ASN90, is a reversible and substrate-competitive O-GlcNAcase enzyme inhibitor. The oral investigational drug is expected to rapidly increase O-GlcNAcylated tau proteins, ...

“When she would fall in public, people just assumed she was drunk,” said Glenn. “One time she fell backwards on the steps and ...

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...

So, let’s talk about faith. I’m no rabbi or scholar, and I’m not trying to write a religious work. But putting my thoughts ...

In The Salt Path, Raynor Winn writes that she and her husband lost their home after investing a “substantial sum” into a ...

Commercial real estate player and former Kislak President Jeffrey Wiener died July 9 after a long battle with progressive ...

Researchers from Asan Medical Center, one of South Korea's largest hospitals, have developed a generative AI model that can ...

TPN-101, a potent nucleoside reverse transcriptase inhibitor that specifically inhibits the LINE-1 reverse transcriptase.

A national charity claims people with severe neurological conditions being unfairly denied access to free care.

Kinetic measures of a cerebrospinal fluid (CSF) biomarker test predicted cognitive decline in Parkinson's disease and distinguished it from progressive supranuclear palsy (PSP), an analysis of ...

Raynor Winn's 2018 memoir The Salt Path is billed as a "true story" based on her and her husband Moth's 630-mile trek along ...

SUDBURY — Roland Joseph Desforges, age 85, passed away in his sleep due to complications from progressive supranuclear palsy, ...